These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 104845)
41. [Tumor immunology. General survey, diagnostic and prognostic aspects, immunotherapy]. Thunold S; Orjasaeter H; Engeset A Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1862-7. PubMed ID: 4129133 [No Abstract] [Full Text] [Related]
42. Cancer vaccines. Dalgleish AG Br J Cancer; 2000 May; 82(10):1619-24. PubMed ID: 10817493 [No Abstract] [Full Text] [Related]
43. Common aspects of immunologic tolerance in pregnancy and malignancy. Gleicher N; Deppe G; Cohen CJ Obstet Gynecol; 1979 Sep; 54(3):335-42. PubMed ID: 382002 [TBL] [Abstract][Full Text] [Related]
44. Tumor immunology and its application to the diagnosis of cancer. Herberman RB Ann Clin Lab Sci; 1974; 4(5):323-30. PubMed ID: 4605405 [No Abstract] [Full Text] [Related]
45. In vitro methods for assessment of antibody-mediated tumor immunity. Levy NL; Amos DB; Solovieff GV; dos Reis AP Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154 [No Abstract] [Full Text] [Related]
46. Effects on tumor growth in vivo by manipulation of the tumor immune response. Sjögren HO Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816 [No Abstract] [Full Text] [Related]
47. [Immunological aspects of tumor pathology]. Piacentini G; Ferrari S Boll Ist Sieroter Milan; 1971; 50(3):199-208. PubMed ID: 5146577 [No Abstract] [Full Text] [Related]
48. [Active immunization: circulating antibodies in experimental hepatoma]. Más M; Chordi A Rev Med Univ Navarra; 1975; 19(1):41-7. PubMed ID: 188089 [No Abstract] [Full Text] [Related]
49. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms]. Rupniewska ZM; Adamczyk MB Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960 [No Abstract] [Full Text] [Related]
51. Demonstration of antibodies in patients' sera, directed against nonspecific cross-reacting antigen. von Kleist S; King M; Havemann K J Natl Cancer Inst; 1978 Dec; 61(6):1385-91. PubMed ID: 281546 [TBL] [Abstract][Full Text] [Related]
52. [Immunological studies on spontaneous colon carcinoma of Wistar-Furth rats: demonstration of tumor antigens and syngeneic anti-tumor antibodies]. Matsuo T Osaka Daigaku Shigaku Zasshi; 1984 Jun; 29(1):86-100. PubMed ID: 6590824 [No Abstract] [Full Text] [Related]
53. [Why does a tumor grow?]. Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837 [No Abstract] [Full Text] [Related]
54. Cellular and humoral immune interactions during neoplastic development. Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716 [No Abstract] [Full Text] [Related]
57. Current aspects of tumor immunology. Preface and introduction. Weiss DW Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649 [No Abstract] [Full Text] [Related]
58. Tumor-associated membrane antigens and the antitumor immune reactions. Levy JP; Kourilsky FM Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056 [No Abstract] [Full Text] [Related]
59. Regression of cancer following surgery. Sindelar WF Natl Cancer Inst Monogr; 1976 Nov; 44():81-4. PubMed ID: 1025476 [TBL] [Abstract][Full Text] [Related]
60. [STUDIES ON SPECIFIC ANTITUMORAL REACTIONS IN PATIENTS WITH KERATOACANTHOMA WITH OBSERVATIONS REGARDING THE INTERFERENCE OF IMMUNITY PROCESSES IN THE SPONTANEOUS CURE OF THAT TUMOR]. NICOLAU SG; BADANOIU A; BALUS L Arch Klin Exp Dermatol; 1963 Sep; 217():308-20. PubMed ID: 14087263 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]